Cantitate/Preț
Produs

Targeted Delivery of Small and Macromolecular Drugs

Editat de Ajit S. Narang, Ram I. Mahato
en Limba Engleză Paperback – 26 iul 2017
Site-specific drug delivery and targeting attracts much research interest from both academia and industry, but because of the many challenges faced in the development of these systems, only a handful of targeted therapies have successfully made it into clinical practice.
Focusing on the delivery technologies that utilize both systemic and local routes of administration, Targeted Delivery of Small and Macromolecular Drugs brings together field experts who summarize current progress and discuss novel ideas currently being explored to overcome these challenges.
The contributors discuss the most promising strategies for drug targeting and also examine targeted drug delivery platforms and technologies at various stages of clinical and preclinical development, including:
    • Active targeting
    • Nucleic acid delivery and targeting
    • Intracellular/organelle-specific strategies
    • Prodrug strategies
    • Organ or tissue-specific drug delivery
    • Drug-polymer conjugates and micelles
    • Stimuli-responsive systems
The book demonstrates why targeted delivery is one of the most exciting contributions pharmaceutical sciences can make to drug therapy.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 45238 lei  6-8 săpt.
  CRC Press – 26 iul 2017 45238 lei  6-8 săpt.
Hardback (1) 110284 lei  6-8 săpt.
  CRC Press – 12 mai 2010 110284 lei  6-8 săpt.

Preț: 45238 lei

Preț vechi: 59026 lei
-23% Nou

Puncte Express: 679

Preț estimativ în valută:
8659 9310$ 7219£

Carte tipărită la comandă

Livrare economică 19 decembrie 24 - 02 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781138114517
ISBN-10: 1138114510
Pagini: 630
Ilustrații: 28; 61 Tables, black and white; 185 Illustrations, black and white
Dimensiuni: 178 x 254 x 32 mm
Greutate: 0.45 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Public țintă

Academic, Professional, and Professional Practice & Development

Cuprins

ACTIVE TARGETING. NUCLEIC ACID DELIVERY AND TARGETING. INTRACELLULAR/ORGANELLE-PART SPECIFIC STRATEGIES. PRODRUG STRATEGIES. ORGAN- OR TISSUE-SPECIFIC DRUG DELIVERY. POLYMER–DRUG CONJUGATES AND MICELLES. STIMULI-RESPONSIVE SYSTEMS.

Notă biografică

Ajit S. Narang works for the Bristol-Myers Squibb, Co. in New Brunswick, New Jersey, in the biopharmaceutical aspects of drug delivery. He has more than eight years of experience in the pharmaceutical industry in the development of oral dosage forms and drug delivery platforms. In addition to the Bristol-Myers Squibb, Co., he has worked for Ranbaxy Research Labs (currently a subsidiary of Daiichi Sankyo, Japan) in Gurgaon, India, and Morton Grove Pharmaceuticals (currently a subsidiary of Wockhardt USA LLC, Parsippany, New Jersey) in Vernon Hills, Illinois. He has more than 35 publications and three pending patent applications, and has contributed to the development of several marketed drug products.

Ram I. Mahato is a full-time professor in the Department of Pharmaceutical Sciences at the University of Health Science Center, Memphis, Tennessee. He was a research assistant professor at the University of Utah, Salt Lake City; a senior scientist at GeneMedicine, Inc., The Woodland, Texas; and a postdoctoral fellow at the University of Southern California in Los Angeles, Washington University in St. Louis, and Kyoto University, Japan. He is an author or coauthor of 79 peer-reviewed articles and book chapters, and has edited/written three books. He is also a special features editor of Pharmaceutical Research and serves on the editorial boards of the Journal of Drug Targeting, Expert Opinion on Drug Delivery, and Transplantation and Risk Management. His research includes delivery and targeting of small molecules, oligonucleotides, siRNA, and genes.

Descriere

Site-specific drug delivery and targeting has attracted much research interest from both academia and industry, but because of the wide array of challenges faced in the development of these systems, only a very few targeted therapies have made it to clinics. Bringing together key research, this volume summarizes current progress with a focus on the novel ideas that are being explored to overcome these challenges. This forward-looking volume includes an in-depth review of various aspects of these drug delivery approaches as well as a detailed discussion of a few case studies in each category.